Back matter
Glossary
The words this guide uses without stopping to define them, in one place. The cytokines have their own spread in Section B.
AnthocyaninsThe purple-blue pigments of bilberries, blueberries and pomegranate; polyphenols with anti-inflammatory activity in the gut (C-01).
BiologicA medication made from a living system, usually an antibody, that blocks one specific immune signal: anti-TNF drugs, ustekinumab, vedolizumab and others.
BDNFBrain-derived neurotrophic factor, the growth factor that lets neurons form and strengthen connections; rises with sleep, movement and learning, falls under chronic inflammation and stress (Section M).
BioavailabilityHow much of a swallowed dose actually reaches the bloodstream or the target tissue. For curcumin, butyrate and the peptides, the form decides it.
ButyrateA short-chain fatty acid made when gut bacteria ferment fiber; the colonocyte's preferred fuel and an epigenetic signal (F-02).
Calprotectin (fecal)A protein released by neutrophils in the gut; measured in stool as a non-invasive marker of intestinal inflammation.
Colloidal dispersionAn ingredient milled into very small particles and kept suspended in liquid; the Theracurmin form of curcumin (Section K, drawn).
ColonocyteThe epithelial cell lining the colon. Runs on butyrate.
CRPC-reactive protein, a blood marker of systemic inflammation driven largely by IL-6.
CytokineA small signaling protein immune cells use to talk to each other; TNF-α, IL-6 and the interleukins are cytokines.
DemulcentA mucilage-rich botanical that coats and soothes a mucous membrane: slippery elm, marshmallow root, aloe inner leaf.
DysbiosisA microbiome that has lost the species that keep it calm and gained the ones that provoke.
EnterocyteThe absorptive epithelial cell of the small intestine. Runs on glutamine.
Enteric coatingA coating that keeps a capsule intact through the stomach so it opens in the intestine; essential for peppermint oil, the whole problem for butyrate.
EpitheliumThe single layer of cells that lines the gut and stands between you and everything you swallow.
Evidence scoreThis guide's 1 to 5 scale for human IBD data specifically. Defined in "How to read this guide."
ExcipientAn inactive ingredient: binder, filler, flow agent, coating. Section K is about which ones matter.
Goblet cellThe epithelial cell that makes and secretes mucus.
IncidenceThe number of new diagnoses over a period of time, usually per 100,000 people per year. Compare prevalence.
ImmunomodulatorA medication that damps the immune system broadly: thiopurines (azathioprine, mercaptopurine), methotrexate.
JAK inhibitorA small-molecule drug that blocks the signaling many cytokines share: tofacitinib, upadacitinib.
Lamina propriaThe connective-tissue layer beneath the epithelium where the gut's immune cells live.
LiposomalActive ingredient enclosed in a phospholipid vesicle to protect it through digestion; quality varies widely (Section K, drawn).
Medical foodA US regulatory category for a food formulated for the dietary management of a condition under medical supervision; not an approved drug. EnteraGam, the prescription form of bovine immunoglobulins, is one (A-04).
Mesalamine (5-ASA)The mainstay anti-inflammatory of ulcerative colitis, acting locally on the gut lining.
MicrobiomeThe trillions of bacteria, fungi and viruses living in the gut, and their genes.
Mucus layerThe gel above the epithelium, built from mucins and phosphatidylcholine; thinned in UC.
NF-κBThe transcription factor that switches inflammatory genes on; the master switch most polyphenols act on.
Nrf2The transcription factor that switches the cell's antioxidant and repair machinery on.
Open-labelA study in which everyone knows who got the treatment; weaker than a blinded trial, and common in supplement research.
PepT1A transporter in the membrane of gut-lining cells whose everyday job is to carry very small protein fragments from digested food into the cell; inflamed colon cells make far more of it, and KPV enters through it (Section G).
PeptideA short chain of amino acids; BPC-157 has fifteen, KPV three.
PhenotypeHow a disease shows up in a particular person: location, behavior, severity. Section N maps entries to it.
PhytosomeA plant compound bound to a phospholipid to carry it across the gut wall: Meriva (curcumin), Casperome (boswellia).
PolyphenolA large family of plant compounds, curcumin, quercetin, resveratrol and EGCG among them, with antioxidant and signaling effects.
PrevalenceThe number of people living with a disease at a given time, usually per 100,000; in IBD it keeps rising for decades after new diagnoses level off, because people live with the disease for a lifetime (front matter).
PrebioticA fiber or compound that feeds beneficial gut bacteria.
ProbioticLive organisms taken for a health effect. Strain-specific; "probiotic" alone tells you little.
RCTRandomized controlled trial; the strongest single study design, and the basis of a 4 or 5 on the evidence scale.
RemissionDisease that is quiet by symptoms (clinical), by scope (endoscopic) or by biopsy (histologic). They are not the same thing.
RepletionRestoring a nutrient the disease has drained, guided by a lab test rather than a trial.
Skeletal formulaThe compact way chemists draw a molecule: unlabeled corners and line ends are carbon, hydrogens on carbon are left out, other atoms are lettered, and lines are bonds (Section B, "A little biology").
Stable IDThe letter-number tag every entry carries, C-08 for example, that never changes between editions.
ThiopurineAzathioprine or mercaptopurine; immunomodulators cleared by an enzyme (TPMT) worth testing before starting.
Tight junctionThe protein seal between neighboring epithelial cells; when it opens, the wall leaks.
Th1 / Th17Programs a T cell can adopt; both drive the inflammation of IBD, steered by IL-12 and IL-23.